- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Good
|
- 20-F Annual report (foreign)
- 4.2 Asset Acquisition Agreement
- 4.3 Share Purchase Agreement
- 8.1 List of Subsidiaries
- 12.1 CEO Certification Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 12.2 CFO Certification Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 13.1 CEO Certification Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- 13.2 CFO Certification Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- 15.1 Consent of KPMG, Independent Registered Public Accounting Firm
- 15.2 Consent of Pricewaterhousecoopers Zhong Tian Cpas Limited Company
- 99.1 Letter, Dated As of September 30, 2009, from KPMG to the Commission
EXHIBIT 13.1
Certification by the Chief Executive Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report of China Medical Technologies, Inc. (the “Company”) on Form 20-F for the fiscal year ended March 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Xiaodong Wu, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: September 30, 2009
By: | /s/ Xiaodong Wu | |
Name: | Xiaodong Wu | |
Title: | Chief Executive Officer |